Weekly Reports | Aug 05 2011
Our top ten news from 29 July 2011 to 05 August 2011 (ranked according to popularity).
Monday 01 August 2011 – 10:00 AM
Weekly update on recommendation, target price, and earning forecast changes.
This story was first published two days ago in the form of an email sent to registered FNArena readers. By Rudi Filapek-Vandyck, Editor
Don't automatically assume growth will translate into the best returns this reporting season.
Australian houses will remain unaffordable for many years to come, suggests the AMP.
Genetic Technologies is a market leader in the checking of breast cancer risk and the potential upside sees RBS Morgans initiate coverage with a Buy rating.
Daily update on share prices and consensus price targets.
Despite a weaker market and weaker credit growth expectations, brokers see a lot of value in Australia's Big Four banks.
The spot uranium price finished July up slightly on June.
FNArena is giving away free tickets to this week's Trading and Investing Expo in Sydney.
Investors in Australia are frustrated and they used the July Survey by FNArena and AIA to blame politicians in Canberra and elsewhere.